Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Total Liabilities (2021 - 2026)

Cingulate's (CINGW) quarterly Total Liabilities came in at $9.6 million in Q2 2026, up 104.0% on a YoY basis from $4.7 million in Q2 2025, and down 23.6% quarter-over-quarter from $12.6 million in Q4 2025.

Analysis

Cingulate (CINGW) Total Liabilities (2021 - 2026) Analysis & Trends

Cingulate (CINGW) has reported Total Liabilities for 6 consecutive years, with $9.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Liabilities rose 104.0% year-over-year to $9.6 million; the trailing twelve-month figure through Jun 2026 stood at $9.6 million (up 104.0% YoY), and the FY2025 full-year result was $12.6 million, up 69.58% from the prior year.
  • Total Liabilities fell to $9.6 million in Q2 2026 per CINGW's latest filing, from $12.6 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $12.6 million in Q4 2025 and bottomed at -$240.0 million in Q2 2025.
  • Historically, Total Liabilities has averaged -$8.1 million across 5 years, with a median of $7.0 million in 2022.
  • The sharpest annual moves came in 2023 and 2025: Total Liabilities surged 599.57% in 2023, then tumbled 11846.65% in 2025.
  • Over 5 years, Total Liabilities stood at $7.5 million in 2022, then surged by 37.72% to $10.4 million in 2023, then fell by 28.49% to $7.4 million in 2024, then jumped by 69.58% to $12.6 million in 2025, then fell by 23.6% to $9.6 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $9.6 million, $12.6 million, and $7.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 644.46 Bn 623.70 Bn 17.26 Bn 116.09 Bn
2 AbbVie 440.11 Bn 433.54 Bn 12.70 Bn 141.05 Bn
3 Merck 365.04 Bn 357.90 Bn 12.21 Bn 23.74 Bn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn 80.09 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn 115.64 Bn
6 Sanofi 52.47 Bn 45.09 Bn 10.79 Bn 69.15 Bn
7 Revolution Medicines 44.26 Bn 44.26 Bn - 1.72 Bn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 1.53 Bn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn 819.80 Mn
10 Cingulate 100,214.03 100,214.03 - 9.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.60 Mn
Dec 31, 2025 12.56 Mn
Sep 30, 2025 7.05 Mn
Jun 30, 2025 -240.00 Mn
Mar 31, 2025 6.54 Mn
Dec 31, 2024 7.41 Mn
Sep 30, 2024 1.54 Mn
Jun 30, 2024 2.04 Mn
Mar 31, 2024 2.28 Mn
Dec 31, 2023 10.36 Mn
Sep 30, 2023 5.97 Mn
Jun 30, 2023 11.33 Mn
Mar 31, 2023 7.08 Mn
Dec 31, 2022 7.52 Mn
Sep 30, 2022 7.01 Mn
Jun 30, 2022 1.62 Mn
Mar 31, 2022 2.41 Mn
Dec 31, 2021 2.04 Mn
Sep 30, 2021 -3.08 Mn
Jun 30, 2021 -1.90 Mn